FDA Approved: DELESTROGEN — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Delestrogen (estradiol valerate) from Par Health USA, LLC, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Menopause
• Postmenopausal Osteoporosis
• Vulvar and Vaginal Atrophy

Drugs mentioned

• DELESTROGEN (ESTRADIOL VALERATE)

Snippet

SUPPL AP for DELESTROGEN (ESTRADIOL VALERATE)